TECHNOLOGY SUMMARY

Current absorbent products for incontinence incorporate additives for odor control. Unfortunately, however, such compositions have proven ineffective in obtaining the full level of odor control desired in many applications. Unicus Pharmaceuticals, LLC has developed a patent-pending SENSEUO™ (Safe, Effective, Non-Toxic, and Spontaneous Elimination of Urine Odor) technology using urine odor eliminating material (UOEM) that would dramatically change the lifestyle of people who are suffering from adult/urinary incontinence. Disposable absorbents have been introduced back in the 1980s but until today no technology could address the related malodor of urine-exposed absorbents. Our novel technology addresses the root cause of the urine malodors which is a unique strategy and one of a kind invention. The potential new products based on our SENSEUO™ or incorporation of SENSEUO™ technology into the existing marketed products will address, for the first time, the malodor coming from urine-soaked absorbent products. This invention will have positive impacts in patients’ quality of life, in various healthcare and care facility settings, and for commercial industries that require large scale urine odor control.

AREA/MATURITY/AWARDS

Primary Application Area: Materials, Chemical

Technology Development Status: Prototype

Technology Readiness Level: TRL 3

Vetted Programs/Awards: Submitted SBIR grant applications.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Showcase Booth #: 22

Website: http://www.unicuspharma.com

GOVT/EXTERNAL FUNDING SOURCES

External Funding to Date: Founder's investment, SBA Loan